As Keffola has mentioned, my understanding is a lot of the trials are supplied at cost, and the margins (30-60% as stated from the company) don't kick in until they sign off on the commercial deals.
Because of that, looking at the previous financial documents for any indication of margin is not going to be accurate. Due to the nature of the product though i believe the company that a margin of 30% is perfectly realistic.
The Negative Thread, page-5
-
- There are more pages in this discussion • 205 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AJX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
1.0¢ |
Change
-0.002(16.7%) |
Mkt cap ! $15.73M | |||
| Open | High | Low | Value | Volume |
| 1.0¢ | 1.1¢ | 1.0¢ | $46.33K | 4.623M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 333885 | 1.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 1.1¢ | 240000 | 2 |
View Market Depth
| Last trade - 16.10pm 31/10/2024 (20 minute delay) ? |
| AJX (ASX) Chart |